Literature DB >> 7682244

T cell epitope specificity in human allergic and nonallergic subjects to bee venom phospholipase A2.

J M Carballido1, N Carballido-Perrig, M K Kägi, R H Meloen, B Wüthrich, C H Heusser, K Blaser.   

Abstract

Phospholipase A2 (PLA) is a biochemically fully defined glycoprotein, representing the main allergen of bee venom. We have established CD4+ T cell clones specific to PLA from subjects allergic and nonallergic to bee sting. By screening the epitope specificity of these clones with 62 synthetic overlapping dodecapeptides representing the PLA molecule, two immunogenic epitopes, PLA81-92 and PLA113-124, were identified. Additional screening, using longer peptides of up to 18 residues, revealed a third epitope at position PLA 45-62. These epitopes are recognized by specific T cell clones in association with HLA-DP and -DQ molecules, although HLA-DR-associated responses to PLA exist. Primary in vitro proliferation of unfractionated PBMC from bee sting allergic, hyposensitized, or hyperimmune subjects to PLA-derived peptides revealed the same immunogenic sites as found in the T cell clones. Among the different groups of individuals, proliferative responses to the PLA molecule and fragments thereof were generally higher in allergic patients than in nonallergic subjects. Thus, at least three linear epitopes are involved in T cell recognition of PLA, independently whether or not subjects are allergic.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682244

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

Review 1.  Molecular characterization of allergens.

Authors:  S S Mohapatra; R F Lockey
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  The role of regulatory T cells in allergy.

Authors:  Maria A Curotto de Lafaille; Juan J Lafaille
Journal:  Springer Semin Immunopathol       Date:  2003-10-22

Review 3.  Hymenoptera venom allergens.

Authors:  Donald R Hoffman
Journal:  Clin Rev Allergy Immunol       Date:  2006-04       Impact factor: 8.667

4.  Use of multiple peptides containing T cell epitopes is a feasible approach for peptide-based immunotherapy in Can f 1 allergy.

Authors:  Anu K Immonen; Antti H Taivainen; Ale T O Närvänen; Tuure T Kinnunen; Soili A Saarelainen; Marja A Rytkönen-Nissinen; Tuomas I Virtanen
Journal:  Immunology       Date:  2007-01       Impact factor: 7.397

Review 5.  Mechanisms of interleukin-10-mediated immune suppression.

Authors:  C A Akdis; K Blaser
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

Review 6.  Peptide and Recombinant Allergen Vaccines for Food Allergy.

Authors:  Quindelyn S Cook; A Wesley Burks
Journal:  Clin Rev Allergy Immunol       Date:  2018-10       Impact factor: 8.667

Review 7.  Immunological mechanisms for desensitization and tolerance in food allergy.

Authors:  Rima Rachid; Dale T Umetsu
Journal:  Semin Immunopathol       Date:  2012-07-21       Impact factor: 9.623

8.  Alteration of the tertiary structure of the major bee venom allergen Api m 1 by multiple mutations is concomitant with low IgE reactivity.

Authors:  Cécile Buhot; Alexandre Chenal; Alain Sanson; Sandra Pouvelle-Moratille; Michael H Gelb; André Ménez; Daniel Gillet; Bernard Maillère
Journal:  Protein Sci       Date:  2004-09-30       Impact factor: 6.725

9.  Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.

Authors:  C A Akdis; M Akdis; T Blesken; D Wymann; S S Alkan; U Müller; K Blaser
Journal:  J Clin Invest       Date:  1996-10-01       Impact factor: 14.808

10.  Characteristics of Prevotella intermedia-specific CD4+ T cell clones from peripheral blood of a chronic adult periodontitis patient.

Authors:  A Wassenaar; C Reinhardus; L Abraham-Inpijn; A Snijders; F Kievits
Journal:  Clin Exp Immunol       Date:  1998-07       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.